Add like
Add dislike
Add to saved papers

Incidence and prevalence of psoriatic arthritis: a systematic review.

OBJECTIVE: Descriptive epidemiological studies of psoriatic arthritis (PsA) in the general population were very limited until the year 2000. Recently, several incidence and prevalence studies of PsA have been reported, suggesting a considerable variation of the disease frequency among different populations. We present a systematic review of incidence and prevalence studies of PsA published after 1987 until December 2006, in order to evaluate and compare their methodology and to summarize their results, and to investigate the possible geographic variations of occurrence of PsA.

METHODS: We conducted a MedLine search including all articles published on PsA incidence and prevalence in the general adult population until December 2006. From each study identified, we extracted the country, year of publication, type of study, criteria of case identification, and incidence or prevalence rates. Methodological criteria for quality included the type of study (prospective or retrospective for incidence studies and retrospective or cross-sectional for prevalence studies), the type of incidence and prevalence rates (crude or adjusted), the criteria of case definition, and the description of the characteristics of the population studied.

RESULTS: A total of 13 studies were identified from the literature search meeting our inclusion criteria. There is a wide variation of annual incidence of PsA (median 6.4, range 0.1-23.1 cases per 105 inhabitants). One incidence study used European Spondylarthropathy Study Group (ESSG) criteria for case definition, while the other studies were based on a coexistence of psoriasis and arthritis in several ways. Three prevalence studies used ESSG criteria for case identification, while the other studies were based on a coexistence of psoriasis and arthritis in several ways. The prevalence estimates vary from 1 case per 105 population in a Japanese study to 420 cases per 105 population in an Italian study (median 180).

CONCLUSION: The occurrence and epidemiological profile of PsA are likely to present important variations among countries and areas of the world. However, several methodological issues and mainly the absence of validated or consensual criteria for case identification and classification of the disease put important limitations on the interpretation of epidemiological data. The establishment of standardized criteria for the diagnosis and classification of PsA cases is necessary for further, valid investigation of the disease epidemiology.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app